Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Jun 15.
Published in final edited form as: Biochemistry. 2010 Jun 15;49(23):4921–4929. doi: 10.1021/bi100244j

Kinetic Mechanistic Studies of Cdk5/p25-Catalyzed H1P Phosphorylation: Metal Effect and Solvent Kinetic Isotope Effect

Min Liu ‡,*, Eleni Girma , Marcie A Glicksman , Ross L Stein §
PMCID: PMC2921628  NIHMSID: NIHMS208803  PMID: 20491486

Abstract

Cdk5/p25 is a member of the cyclin-dependent, Ser/Thr kinase family and has been identified as one of the principle Alzheimer’s disease-associated kinases which promote the formation of hyperphoshorylated tau, the major component of neurofibrillary tangles. We and others have been developing inhibitors of cdk5/p25 as possible therapeutic agents for Alzheimer’s disease (AD). In support of these efforts, we examine the metal effect and solvent kinetic isotope effect on cdk5/p25-catalyzed H1P (a histone H-1-derived peptide) phosphorylation. Here, we report that a second Mg2+ in addition to the one forming the ATP-Mg complex is required to bind to cdk5/p25 for its catalytic activity. It activates cdk5/p25 by demonstrating an increase in kcat and induces a conformational change that favors ATP binding but has no effect on the binding affinity for the H1P peptide substrate. The binding of the second Mg2+ does not change the binding order of substrates. The reaction follows the same rapid equilibrium random mechanism in the presence or absence of the second Mg2+ as evidenced by initial velocity analysis and substrate analogue and product inhibition studies. A linear proton inventory with a normal SKIE of 2.0 ± 0.1 in the presence of the second Mg2+ was revealed and suggested a single proton transfer in the rate-limiting phosphoryl transfer step. pH-profile revealed a residue with a pKa of 6.5 that is most likely the general acid-base catalyst facilitating the proton transfer.


One of the pathological hallmarks of Alzheimer’s disease (1, 2) is neurofibrillary tangles (NFT). The major component of NFTs is hyperphosphorylated tau, the microtubule-associated protein (3). Cdk5/p25 has been identified as one of the principle AD-associated kinases due to the increased activity of cdk5/p25 in the AD brain and its ability to phosphorylate tau at multiple sites (46). Cdk5/p25 is a proline-directed Ser/Thr kinase and a member of the cyclin-dependent kinase family involved in cell cycle regulation. Unlike other members of the family that require association with a cyclin for activity, cdk5 associates with the activator protein p35. The resultant complex cdk5/p25 of the neuronal-specific processing of p35 to p25 by calpain likely plays a role in the pathogenesis of AD (57).

With our understanding of the role of cdk5/p25 in the AD brain, discovery and design of inhibitors of this enzyme have become a goal in the search for drugs to treat AD. Understanding the mechanism of cdk5/p25 is critical for the design of inhibitors. We previously reported a random kinetic mechanism for cdk5/p25 catalysis (8). In this article, we reveal additional features of cdk5/p25 catalysis discovered by probing the metal, pH, and solvent isotope effects.

Many kinases have been reported to bind to a second metal ion for catalytic activity in addition to the one required to form the nucleotide-metal complex. Mg2+ is considered the physiological metal of kinases due to its high concentration in the cell compared with other divalent metal ions, although catalytic activity is detected also with Mn2+, Co2+, and, Cd2+(910). Herein we report that (I) cdk5/p25-catalyzed H1P phosphorylation requires the binding of a second Mg2+ for its catalytic activity; (II) the binding of the second Mg2+ induces a conformational change that does not limit the access of either substrate, although it favors ATP binding; and (III) in the presence of the second Mg2+ the phosphor transfer step is the rate-limiting step and associated with a single proton transfer, which is facilitated by a general acid-base catalyst.

MATERIALS AND METHODS

Materials

Adenosine 5’-triphosphate (ATP), phosphoenolpyruvate, magnesium chloride, NADH, 2-(N-morpholino)propanesulfonic acid (MOPS), trichloroacetic acid (TCA), bovine serum albumin, pyruvate kinase type II from rabbit muscle, and lactate dehydrogenase type II from bovine heart were purchased from Sigma (St. Louis, MO). Dithiothreitol (DTT) was from Fluka (St. Louis, MO). Histone H1-derived peptide PKTPKKAKKL (H1P) was purchased from Anaspec (San Jose, CA). H1P analogue H1PAla (PKAPKKAKKL) was purchased from American peptides (Sunnyvale, CA). [γ-33P]-ATP was from PerkinElmer (Boston, MA). Cdk5/p25 was generously provided by Dr. Ken Kosik of the University of California, Santa Barbara.

Kinetic Analysis of H1P Phosphorylation by Cdk5/p25

The kinase assay was conducted in buffer containing 20 mM MOPS (pH 7.5), 1 mM DTT, BSA 0.5 mg/ml, MgCl2, H1P (PKTPKKAKKL), ATP, and [γ-33P]-ATP. The reactions were conducted in triplicate, initiated by the addition of 7.8 nM cdk5/p25, and incubated at RT for 30 min. The reaction was stopped by the addition of 10 mM EDTA and the mixture was transferred to a multiscreen PH filtration plate (Millipore, Billerica, MA) and washed six times with 75 mM H3PO4. The filters were removed and the samples were counted with a scintillation counter. Background reaction was conducted in the absence of H1P. In all cases, reaction progress curves for production of phospho-protein were linear over at least 45 minutes, and allowed calculation of initial velocities.

Buffer Salts for pH Dependencies

In all of these kinetic studies, reaction solutions contained 20 mM buffer salt, 50 mM NaCl, 2.5 mM MgCl2, 1 mM DTT, 0.5 mg/ml BSA. The following buffer salts were used: MES at pH 5.5–6.5, PIPES at pH 6.5–7.0, HEPES at pH 7.0–8.0, HEPBS at pH 8.5–9.0, and CHES at pH 9.5–10.0.

Data Analysis

Data were analyzed by nonlinear least-squares, using either Sigma-Plot or Grafit software packages. Standard kinetic mechanisms for two-substrate reactions and their rate equations are shown below: Ping-Pong:

ν=kcat[E][A][B]KA[B]+KB[A]+[A][B] (1)

KA and KB are Michaelis constants. Rapid Equilibrium Ordered:

ν=kcat[E][A][B]KAKB+KB[A]+[A][B] (2)

KA and KB are substrate dissociation constants from EA and EB, respectively. Rapid Equilibrium Random/Steady-State Ordered:

ν=kcat[E][A][B]αKAKB+αKA[B]+αKB[A]+[A][B] (3)

Replot equations for random mechanism:

(kcat)A=kcat([B]αKB+[B]) (4)
(kcat/Km)A=kcatαKA([B]KB+[B]) (5)

For rapid equilibrium systems, KA, KB, αKA, and αKB are substrate dissociation constants from EA, EB, and EAB. For steady-state systems, KA is the substrate dissociation constant from EA and αKA and αKB are Michaelis constants. See Segel for definitions of mechanisms, substrate dissociation constants, and α (11).

RESULTS

Initial Velocity Studies

The effect of free Mg2+ on cdk5/p25-catalyzed H1P phosphorylation was studied by the use of initial velocity studies as discussed by Cook (1213). Experiments were performed in which the initial velocities were measured as a function of H1P concentration, at several fixed concentrations of MgATP (331, 166, 83, 42, 21 µM) and at a single fixed concentration of free Mg2+ at 0.2 mM (Figure 1A). This experiment was repeated at four concentrations of free Mg2+, 0.6, 1.3, 2.5, and 5 mM. Magnesium ions in excess of that needed to bind ATP were assumed to be free Mg2+ and the dissociation constant of MgATP (14.3 µM) (14) was used to calculate the concentrations of MgATP and free Mg2+. Extra care and calculation were taken in order to keep the concentration of free Mg2+ as a constant for the entire range of MgATP concentration. Each data set was subjected to global analysis by nonlinear least-squares fits to the equations that reflect ping-pong, rapid equilibrium ordered, and random/steady-state ordered mechanisms (eq 1eq 3). Statistically the data fit the equation reflecting the rapid equilibrium random/steady-state ordered mechanism the best and the parameters analyzed for 0.2 mM and 2.5 mM Mg2+ are summarized in Table 1. To examine the data carefully and judge among the mechanisms, we also used the method of replots as described previously (8). The starting point in this data analysis was to calculate apparent values of (kcat)X and (kcat/Km)X (X = H1P or ATP) by nonlinear least-squares fits of each individual plot of v0 vs [X] in the primary data sets to the simple Michaelis-Menten equation. The next step in this analysis was to construct the replots of the dependencies of apparent values of (kcat)A and (kcat/Km)A on [B] and the dependencies of apparent values of (kcat)B and (kcat/Km)B on [A] and examine their shape. Replots will show a specific, mechanism-based pattern. For example, for the random mechanism of eq 3, apparent values of (kcat)A and (kcat/Km)A will be hyperbolically dependent on [B] according to the equations given in eq 4 and eq 5. Likewise, apparent values of (kcat)B and (kcat/Km)B will be hyperbolically dependent on [A].

Figure 1.

Figure 1

Steady-state kinetic experiment for cdk5/p25-catalyzed H1P phosphorylation at free Mg2+ of 0.2 mM. Panel A: Dependence of initial velocity on H1P concentration at MgATP concentration of 331 (●), 166 (○), 83 (▼), 41.5 (∇), and 21 (▪) µM. Each data point is the average of duplicate measurements. The data were globally fit to the equation reflecting rapid equilibrium random/steady-state mechanism. Panels B and C: MgATP concentration dependencies of (kcat)H1P and (kcat/Km)H1P. Apparent values (kcat)H1P and (kcat/Km)H1P were calculated by fitting the individual plot of v0 vs [H1P] of panel A to the simple Michaelis-Menten equation.

Table 1.

Initial Velocity Analysis for Cdk5/p25-Catalyzed H1P Phosphorylation at Low and High Free Mg2+ Concentrationsa

0.2 mM Mg2+ 2.5 mM Mg2+
kcat, s−1 0.77 ± 0.04 3.6 ± 0.2
KH1P, µM 12 ± 0.7 7 ± 0.5
KATP, µM 60 ± 20 6.1 ± 1.5
α 16 ± 2 12 ± 1.7
a

The parameter estimates were calculated by globally fitting the data into the equation reflecting rapid equilibrium random/steady-state order mechanism. Each parameter estimate is the average of two independent experiments. The error limit is the deviation from the mean.

Replots of apparent values of (kcat)H1P and (kcat/Km)H1P vs [MgATP] and apparent values of (kcat)MgATP and (kcat/Km)MgATP vs [H1P] through the whole range of free [Mg2+] all revealed hyperbolic dependencies on substrate concentration, suggesting that the reaction follows either a random or a steady-state ordered mechanism. An example of these replots at 0.2 mM Mg2+ was shown in Figure 1B and 1C. A sigmoid kinetic behavior was observed in Figure 1B and data was fitted to an equation reflecting sigmoidicity: v = vc/(1 + (KS/[S])^n), yielding a hill coefficient of 1.8 ± 0.1. To distinguish between the two mechanisms, we conducted substrate analogue and product inhibition studies (see below). Next we examined the effects of Mg2+ on the steady-state kinetic parameters and the results are shown in Figure 2. The zero free Mg2+ cannot be achieved in the presence of MgATP, therefore, the effect of zero free Mg2+ can only be extrapolated from higher Mg2+ concentrations. Increasing free Mg2+ concentration resulted in an increase in kcat with the maximal kcat being achieved at 5 mM Mg2+ (Figure 2A). Increasing free Mg2+ concentration also resulted in an increase in kcat/KH1P (Figure 2B), which is mainly due to the increase in kcat at high Mg2+ concentration. The values of KH1P remain almost the same through the entire Mg2+ concentration range, 12 ± 0.7 µM at 0.2 mM free Mg2+, 11 ± 0.8 µM at 1.3 mM free Mg2+, and 7 ± 0.5 µM at 2.5 mM free Mg2+. However, the values of KMgATP decrease with increasing free Mg2+ concentration, 60 ± 20 µM at 0.2 mM free Mg2+ and 6.1 ± 1.5 µM at 2.5 mM free Mg2+. The much lower sensitivity at low Mg2+ concentration contributed to the large error for KMgATP. The increases in both kcat and MgATP binding affinity lead to an increase in kcat/KMgATP (Figure 2C). The data in Figures 2A and 2B were fitted to an expression of enzyme activation that requires binding of one activator to achieve full activity: v = vc/(1 + (KA/[A]), yielding dissociation constants for Mg2+ of 0.6 ± 0.07 and 0.6 ± 0.2 mM under the conditions of kcat, kcat/KH1P. A sigmoid kinetic behavior was observed under the condition of kcat/KMgATP (Figure 2C) and data was fitted to an equation reflecting sigmoidicity: v = vc/(1 + (KA/[A])^n), yielding dissociation constant for Mg2+ of 1.7 ± 0.1 mM and a hill coefficient of 2.1 ± 0.3.

Figure 2.

Figure 2

Free Mg2+ effect on steady-state parameters. (A) Dependences of kcat (B) kcat/KH1P and (C)kcat/KATP on concentrations of free Mg2+.

To ensure that the additional magnesium requirement is not a result of a nonspecific ionic effect, we measured cdk5/p25 activity at different NaCl concentrations. The activity of cdk5 remained the same at NaCl concentrations less than 80 mM, but decreased at high concentrations of NaCl (data not shown).

Inhibition Studies with Substrate Analogues and Product ADP

To determine the kinetic mechanism of cdk5/p25-catalyzed H1P phosphorylation at low Mg2+, inhibition studies were conducted with nucleotide analogue AMP, product ADP, and peptide substrate analogue H1PAla (PKAPKKAKKL) at 0.2 mM MgCl2. We first determined at several concentrations of inhibitor, (i) the dependence of v0 on [H1P] at a single [ATP]; (ii) the dependence of v0 on [ATP] at a single [H1P]. Examples of [ATP]-dependence of initial velocity for AMP and H1PAla inhibition are shown in Figures 3A and 3D. Next we analyzed for (i) the dependence of v0 on [H1P] at each [I] and for (ii) the dependence of v0 on [ATP] at each [I], by nonlinear least-squares fit to the simple Michaelis-Menton equation to calculate apparent values of (kcat)X and (kcat/Km)X (X = ATP or H1P). Finally in this analysis we constructed the replots of apparent values of (kcat)X vs [I] and apparent values of (kcat/Km)X vs [I]. Examples of these replots for AMP as an inhibitor are shown in Figures 3B and 3C and examples for H1PAla are shown in Figures 3E and 3F. We found that when ATP was the variable substrate: (i) for AMP or ADP inhibition, (kcat)ATP is independent of AMP or ADP and (kcat/Km)ATP titrates with AMP or ADP according to the simple inhibition expression of general form: vinhib = vcontrol/(1 + [I]/Ki,app); (ii) for H1PA inhibition, (kcat)ATP is independent of H1PAla and (kcat/Km)ATP titrates with H1PAla. When H1P was the variable substrate: (i) for AMP or ADP inhibition, both (kcat)H1P and (kcat/Km)H1P titrate with AMP or ADP; (ii) for H1PAla inhibition, (kcat)H1P is independent of H1PAla and (kcat/Km)H1P titrates with H1PAla. This suggests that H1PAla is competitive with both ATP and H1P; AMP or ADP is competitive with ATP and noncompetitive with H1P.

Figure 3.

Figure 3

Inhibition of the cdk5/p25-catalyzed H1P phosphorylation by substrate analogues H1PAla and AMP at 0.2 mM Mg2+ concentration. Panels A and B: Inhibition by H1PAla, (A) the dependence of Ki,app on H1P, (B) the dependence of Ki,app on ATP. Panels C and D: Inhibition by AMP, (C) the dependence of Ki,app on ATP, (B) the dependence of Ki,app on H1P.

These patterns rule out a steady-state ordered mechanism, but are different from the ones well known for a rapid equilibrium random mechanism in which it has been assumed that the competitive inhibitors act as dead-end inhibitors and bind to the same enzyme form as the substrates (15). The patterns seen in this study clearly suggest that the inhibitors interact with the enzyme in a different mode. To examine these results and estimate the values of dissociation constants, we used the method previously described in detail (8), where the general mechanism of Scheme I, in which inhibitor can bind to all four forms of enzyme, was used to derive the rate equation (eq 6) under rapid equilibrium condition.

ν=kcat[E][A]1+αKB[B]+αKB[B][I]Ki,ea+[I]Ki,eabKA{α+αKB[B]+αKB[B][I]Ki,e+[I]Ki,eab1+αKB[B]+αKB[B][I]Ki,ea+[I]Ki,eab}+[A] (6)

Scheme I.

Scheme I

Rapid equilibrium random mechanism of cdk5/p25-catalyzed phosphorylation. A represents ATP, and B represents H1P.

By inspecting eq 7eq 10 which describe the dependencies of apparent values (kcat)X and (kkcat/Km)X (X = ATP, or PLK-peptide) on inhibitor, we can immediately see how inhibitors interact with the enzyme.

(kcat)ATP=kcat[E]1+αKB[B]+αKB[B][I]Ki,ea+[I]Ki,eab (7)
(kcat/Km)ATP=kcat[E]/αKA1+KB[B]+KB[B][I]Ki,e+[I]αKi,eb (8)

In the case of H1PAla inhibition where ATP is the variable substrate, (kcat)ATP is independent of H1PAla, which suggests that both Ki,ea and Ki,eab are very large and H1PAla cannot bind to either E:A or E:A:B complex. On the other hand, (kcat/Km)ATP titrates with H1PAla suggesting that H1PAla can bind to E, E:B or both. It is clear that at this point, we cannot calculate independent estimates of Ki,e and Ki,eb.

We can however, obtain this information from inspecting eq 9 and eq 10. In the case where PLK-peptide is the variable substrate, (kcat)PLK is independent of H1PAla which suggests that both Ki,eb and Ki,eab are very large and H1PAla cannot bind to either E:B or E:A:B complex; (kcat/Km)PLK titrates with H1PAla, suggesting that H1PAla can bind to E or E:A.

(kcat)PLK=kcat[E]1+αKA[A]+αKA[A][I]Ki,eb+[I]Ki,eab (9)
(kcat/Km)PLK=kcat[E]/αKB1+KA[A]+KA[A][I]Ki,e+[I]αKi,ea (10)

Using this method, we can identify the enzyme forms that inhibitors bind and estimate the dissociation constants as follows: (i) H1PAla binds only to free enzyme and Ki,e was estimated directly from eq 8 or eq 10 with our previous knowledge of kcat, KA, KB, and α; (ii) AMP behaves as a dead-end inhibitor and binds to both E and E:B complex. Ki,eb was estimated directly from eq 9, Ki,e directly from eq 10, and Ki,e also from use of Ki,eb and eq 8. The mechanism of inhibition and dissociation constants for H1PAla, AMP, and ADP at low Mg2+ concentration are summarized in Table 2.

Table 2.

Inhibition of Cdk5/p25 by Substrate Analogues at 0.2 mM Mg2+

substrate mechanism inhibn const (mM)

inhibitor fixed variable Ki,e Ki,es
AMP ATP H1P NC 2.7 ± 0.3 1.4 ± 0.5
H1P ATP C 2.5 ± 0.7
ADP ATP H1P NC 0.6 ± 0.1 0.3 ± 0.1
H1P ATP C 0.3 ± 0.1
H1PAla ATP H1P C 0.2 ± 0.1
H1P ATP C 0.6 ± 0.3

pH-Dependence of Steady-State Kinetic Parameters of H1P Phosphorylation

The pH stability of cdk5/p25 was determined by incubating enzyme at the desired pH and assaying aliquots at pH 7. Enzyme is stable from pH 6 to 9. Small activity lose occurs at pH 5.5 and 10.0. The phosphorylation of H1P was monitored in a pH range of 5.5 −10.0 under conditions of variable H1P (0 – 480 µM) and fixed ATP (800 µM) at high Mg2+ concentration (5 mM). Plots of v0 versus H1P concentration were used to determine kcat and kcat/KH1P. The pH profile of kcat showed a bell-shaped curve (Figure 4) and was fitted to equation 11 yielding two apparent pKa’s of 6.1 and 10.0, respectively. The involvement of an alkaline residue in the catalysis is questionable because of activity loss at higher pH due to protein denaturation. Also, an alkaline group with pKa of 8.3 was revealed in the ATPase reaction (see below). It is possible that the activity loss at higher pH could simply be due to protein denaturation rather than the titration of an alkaline residue. The kcat/KH1P exhibited a similar pH dependence as kcat owing to the pH insensitivity of KH1P (data not shown).

Figure 4.

Figure 4

pH dependence of kcat for the cdk5/p25-catalyzed H1P phosphorylation. The experiments were conducted under conditions of variable H1P (0–480 µM) and fixed ATP (800 µM) at 5 mM Mg2+. The data was fit to equation 11.

y=C1+10pH/10pKal+10pKa2/10pH (11)

As mentioned in the previous study, cdk5/p25 possesses an ATPase activity with a kcat 15-fold less than that for the kinase activity. Since transfer to water is slow, the phosphoryl transfer rate is almost certain to be rate-determining. A pH study was carried out for the cdk5/p25-catalyzed ATP hydrolysis. The Km for ATP was found to be 20, 11, 8, and 10 µM at pH values of 6, 7, 8, and 9, respectively. The pH profile of kcat for ATP hydrolysis showed a bell-shaped curve and was fit to equation 11 yielding two apparent pKa’s of 6.3 and 8.3 as shown in Figure 5A. The bell-shaped curve was also found in the pH profile of kcat/KATP without perturbation of two pKa’s by fitting the data to equation 11 as shown in 5B. Buffer crossover experiments revealed no dependence on the buffer salt. Comparison of the pH profiles of kcat of the kinase and ATPase reactions revealed similar pKa’s on the acid side, while the alkaline pKa’s are quite different. It is possible that the group giving rise to the alkaline pKa in the ATPase reaction is no longer involved in catalysis.

Figure 5.

Figure 5

pH profiles of the ATPase reaction of cdk5/p25. (A) pH-dependence of kcat and (B) pH-dependence of kcat/KATP. The experiments were conducted under conditions of variable ATP at 5 mM Mg2+. The data was fit to equation 11.

Proton Inventory Study

The proton inventory study was carried out for kcat (initial velocity was measured at saturating concentrations of both ATP and H1P) at low (0.2 mM) and high (5 mM) Mg2+ concentrations in the mixture of H2O and D2O at pH 7.4 and pD equivalent. The dependence of the ratio of kcat (kn/k0) in the presence and absence of varying atom fractions of D2O (n) on n at high and low Mg2+ concentration is presented in Figure 6. At high Mg2+ concentration, kn/k0 decreases linearly with n. The solvent deuterium isotope effect on kcat can be expressed by the linear form of the Gross-Butler equation (16) with only one exchangeable hydrogen site:

kn/k0=(1n+nϕT)/(1n+nϕR) (12)

where ϕR and ϕT are fractionation factors for the exchangeable hydrogen in the reactant and transition state, respectively. The fitting of data to the equation gives the following estimates: ϕR = 1 and ϕT = 0.47. Given this, we can assign the estimate to SKIE for kcat, Dkcat = ϕRT = 2.0 ± 0.1 determined from three independent experiments. To make certain that changes in side chain pKa’s in light and heavy water are not causing a dramatic difference to SKIE, the proton inventory study for kcat was repeated at low (0.2 mM) and high (5 mM) Mg2+ concentrations in the mixture of H2O and D2O at pH 8.0 and pD equivalent. No dramatic differences on SKIE were observed and SKIE of 1.8 ± 0.1 and 1.0 ± 0.1 were determined from three independent experiments at high and low Mg2+. At low Mg2+ concentration, a linear proton inventory and SKIE value of 1.1 ± 0.1 were observed for kcat (Figure 6). The proton inventory study was also carried out at high and low Mg2+ concentrations on kcat/KH1P (initial velocity was measured at a saturating concentration of ATP and a concentration of H1P 10-fold less than KH1P) and kcat/KATP (initial velocity was measured at a saturating concentration of H1P and a concentration of ATP 10-fold less than KATP) in three independent experiments. At both high and low Mg2+ concentrations, linear proton inventory and SKIE values close to 1 were found for these parameters and summarized in Table 3.

Figure 6.

Figure 6

Proton inventory of kcat for the cdk5/p25-catalyzed H1P phosphorylation at 5 mM Mg2+ (○) and 0.2 mM Mg2+ (●). kcatn/kcat0 is the ratio of kcat in the presence and absence of varying atom fractions of deuterium (n). Initial velocities were determined at saturating concentrations of both ATP and H1P.

Table 3.

SKIE Parameters for the Cdk5/p25-Catalyzed H1P Phosphorylation at Low and High Free Mg2+ Concentrations

0.2 mM Mg2+ 2.5 mM Mg2+
D(kcat) 1.1 ± 0.1 2.0 ± 0.1
D(kcat/KA) 1.0 ± 0.1 1.0 ± 0.1
D(kcat/KB) 1.0 ± 0.1 1.0 ± 0.1
a

The dependence of the ratio of each kinetic parameter on varying atom fractions of D2O (n) was fit to the Gross-Bulter equation kn/k0 = (1 − n + nϕT)/(1 − n + nϕR). SKIE was estimated as the ratio of ϕRT. Each parameter estimate is the average of three independent experiments. The error limit is the deviation from the mean.

Influence of D2O on Inhibitor Binding

The dissociation constant for the ATP competitive inhibitor AMP was measured in pure H2O and 85% D2O under conditions of 10 µM ATP and saturating H1P concentration. The dependence of v0 on [I] was analyzed by nonlinear least-squares fit to the expression vinhi = vcontrol/[1+([I]/Ki,app)] to determine Ki,app.

DISCUSSION

Many kinases have been reported to bind to a second metal ion in addition to the one required to form the nucleotide-metal complex, though the role of the second metal varies in each case. For example, a second metal ion activates Csk and Src by increasing the kcat without affecting the KATP (16). However, it activates IRK and v-Fps by decreasing the KATP without affecting the kcat (1718). More interestingly, the second Mg2+ binding in the active site of cAMP-dependent protein kinase (PKA) inhibits the kinase activity by decreasing its kcat (19). In this study we report the effect of the second Mg2+ on the cdk5/p25-catalyzed H1P phosphorylation.

Kinetic Mechanism

The initial velocity study of the cdk5/p25-catalyzed H1P phosphorylation at different concentrations of Mg2+ revealed that a second Mg2+ is required to bind to cdk5/p25 for its catalytic activity. It activates cdk5/p25 by demonstrating an increase in kcat. The binding of the second Mg2+ facilitates ATP binding by demonstrating a dramatic decrease in KATP. Likewise, the binding of ATP also favors the binding of the second Mg2+; the saturation of ATP in the active site decreases the dissociation constant of the second Mg2+ by 3-fold. More surprisingly, sigmoid kinetic behavior was observed on the binding of ATP at low concentration of Mg2+ and on the binding of Mg2+ at low concentration of ATP as demonstrated by a hill coefficient of about 2 in each case. At either low Mg2+ or low ATP concentration, the two subunits of the cdk5/p25 dimer interact cooperatively and permit much more sensitive response to the ligand concentration (either ATP or Mg2+). On the other hand, the presence of the second Mg2+ makes this type of cooperative interactions unnecessary by inducing a conformational change which favors ATP binding without limiting the access of either substrate. A rapid equilibrium random mechanism in the absence of the second Mg2+ was revealed by substrate analogue and product inhibition studies, which is consistent with a random mechanism in the presence of the second Mg2+ as reported in a previous study (8).

The discrete mechanism of the second Mg2+ coordinated in its interaction with cdk5/p25 is kinetically complex. It might bind to a site other than the active site of the enzyme and induce a conformational change. This hypothesis is supported by the crystal structure of cdk2, which is a member of the cyclin-dependent kinase family and shares 60% sequence identity with cdk5. In the co-crystal structure of cdk2-cyclinA3 with both a peptide substrate and an ATP analogue, there is only one bound Mg2+ chelating the α- and γ-phosphates in the active site (20). It is also possible that the second metal was not observed in the crystalline state due to the experimental conditions (the crystal was grown in the presence of 5 mM Mg2+), and actually it is coordinated within the active site of the enzyme and participates in catalysis directly. This hypothesis is supported by the mutual effects of free Mg2+ and ATP observed on the binding of the other: the KATP was lowered by 10-fold at saturating Mg2+, and likewise the Kd of free Mg2+ was decreased significantly at saturating ATP. Many kinases require a second metal ion for the catalytic activity, such as phosphoenolpyruvate carboxykinase (PEPCK), protein tyrosine kinase, and LRRK2 (2123). Evidence from these kinases also supports the second hypothesis. For example, crystallographic structure of PEPCK revealed the coexistence of Mg2+ and Mn2+ in the active site at two distinct locations (22). The two metal ions make contacts with ATP and different amino acid residues, with Mg2+ chelating both the β- and γ-phosphate of ATP. We propose that the second Mg2+ directly binds to the active site of cdk5/p25 and contacts with β- or γ-phosphate of ATP through either direct or water-mediated interactions.

The fact that Mg2+ modulates the activity of cdk5/p25 may have physiological consequences worth noting. The activity of cdk5/p25 could be modulated in vivo by changes in free cytoplasmic Mg2+ concentration.

Proton Transfer

Based on the chemical principle of phosphoryl transfer, the hydroxyl proton must be removed to form products. Therefore, the study of phosphoryl transfer catalyzed by kinases is inevitably linked to the study of its proton transfer mechanism. In order to further our understanding of the role of the second Mg2+ in the H1P phosphorylation, a proton inventory study was conducted at both high and low Mg2+ concentrations. The use of the shape of the proton inventory and the size of the solvent isotope effect to determine the number of hydrogenic sites and diagnose the mechanism have been well discussed by Schowen and Venkatasubban (2526).

A. Proton Transfer and Rate-Determining Step at High Mg2+ Concentration

A normal SKIE (2.0) was observed on kcat at high Mg2+concentration. In order to interpret the isotope effect on cdk5/p25 catalyzed H1P phosphorylation, it is important to know whether the larger intrinsic viscosity of D2O or an equilibrium isotope effect on a catalytic residue or on buffer pKa provided the sources for the observed SKIE. First, the observed SKIE is much larger than the predicted influence of D2O due to viscosity. Since D2O is 20% more viscous than H2O, the effects of increased viscosity would account for only 5% rather than the observed 50% change in turnover rate. Second, the lack of SKIE on kinetic parameters at low Mg2+ (see below) ruled out the possibility that the observed SKIE is due to an equilibrium isotope effect. With these as foundations, proton inventory can be interpreted. The linear proton inventory with normal SKIE (2.0) observed with kcat at high Mg2+ concentration suggests that (i) a single protonic interaction in the catalytic transition state is responsible for the solvent isotope effect-that is, one-proton catalysis, and binding at this protonic site is looser in the transition state than in the reactant state, and (ii) phosphoryl transfer is the rate-limiting step of the process governed by kcat. In an independent study to measure the pre-steady-state kinetics using a rapid quench flow technique, the phosphorylation of H1P exhibited no burst kinetics for kcat which is consistent with a slow phosphoryl transfer and a rapid product release mechanism (data not shown).

Since the enzyme follows a rapid equilibrium random mechanism at high Mg2+ concentration, it is reasonable to assume that the substrate is in rapid exchange with the enzyme. As a result, SKIE is anticipated in the parameter kcat/KH1P or kcat/KATP. Surprisingly, no SKIE was observed in either. The lack of SKIE on kcat/KH1P or kcat/KATP may suggest that during the process governed by kcat/Km, the enzyme-substrate complex E:A or E:S undergoes a slow deuterium-insensitive step preceding the phosphoryl transfer step, but the inhibition data suggest another solution. The dissociation constant of AMP from E:H1P:AMP was found to be lower in 85% D2O compared with water by approximately 1.5-fold (data not shown). The solvent isotope effect on the dissociation constant originates from solvent reorganization that accompanies substrate or inhibitor binding and generally ranges from 1.2 to 1.8 (27). Based on a predicted SKIE of 1.6 for kcat at 85% D2O, the equilibrium isotope effect on substrate binding offsets SKIE so that no SKIE is observed for kcat/KATP or kcat/KH1P. Scheme II depicts the random mechanism for cdk5/p25-catalyzed H1P phosphorylation at high Mg2+ concentration, where the binary substrate complex E:S or EA binds to the second substrate to form the active central complex E:ATP:S controlled by the association rate constant k2 and dissociation rate constant k-2. The catalytic step, k3, describes the unimolecular rate constant for the chemical transfer as well as any conformational change associated with this step. Finally, the release of product and the conformational change associated with it is combined in k4. Rate equations for kcat and kcat/Km of Scheme II were derived by using Cleland’s methods of net rate constants (28):

kcat=k3k4/(k3+k4) (13)
kcat/Km=k2k3/(k2+k3) (14)
Scheme II.

Scheme II

Due to the relatively rapid process of product release (k4 > k3), kcat becomes approximately equal to k3. Based on the assumption that substrate is in rapid exchange with the enzyme (i.e k-2>k3), kcat/Km could be simplified into the expression as in equation 15.

kcat/Km=k2k3/k2 (15)

We commonly refer to the Km as an apparent affinity since it does not provide a direct measure of the real affinity of the substrate and the kinase (Kd). Adams and colleagues reported that the Km values obtained in the steady-state kinetic analyses may contain terms related to steps occurring in the central ternary complex. They further explained how fast and favorable phosphoryl transfer can overcome weak interactions between the enzyme and substrate and further increase apparent affinity in the thermodynamically coupled systems (24). Considering this, we examined Km for cdk5/p25-catalyzed H1P phosphorylation at high Mg2+. For substrate recognition, Km includes all the rate constants in the reaction scheme II as shown below:

Km=(k2+k3)k4/k2(k3+k4) (16)

Since k-2> k3 < k4, the complex expression of Km can be simplified into the approximation given by equation 17:

Km=k2/k2 (17)

That is exactly the same expression of the real substrate affinity Kd. Like the case observed by Adams, we found that the slow phosphoryl transfer of H1P phosphorylation at high Mg2+ concentration (k-2 > k3 <k4) allows a direct measurement of Kd from Km.

B. Proton Transfer and Rate-limiting Step at Low Mg2+ Concentration

No SKIE was detected on kcat, kcat/KATP, or kcat/KH1P at low Mg2+ concentration. The lack of SKIE on kcat should be interpreted cautiously and three mechanisms are possible. First, if the phosphoryl transfer step in the transition state is preceded or followed by a slow conformational change, small or no SKIE would be detected for kcat. Second, if the product release step represented as k4 in Scheme II is relatively slow (k3>k4), then kcat is approximately equal to k4 and the observed SKIE would be greatly diminished. Third, if the hydroxyl proton was abstracted after the transfer of the γ–phosphate, little or no SKIE would be observed. No special driving force is required for this proton transfer since the pKa’s of the O-phosphono-threonine is very low (29). This mechanism is not likely, though, due to the SKIE detected on kcat at high Mg2+ concentration (see the discussion below). The lack of SKIE on kcat/KATP or kcat/KH1P could be interpreted as a slow conformational change associated with the chemical transfer step.

Is there a general base in the catalysis?

The observation of large kinetic SKIE on cdk5/p25-catalyzed H1P phosphorylation suggests that the hydroxyl proton was abstracted by a general base in the active site. Indeed, there is structural evidence from the X-ray analysis of members of the cdk family that a conserved aspartate (Asp-127 in cdk2, Asp-126 in cdk5) is within hydrogen-bonding distance of the hydroxyl and, therefore, may serve as a general-base catalyst. The dependence of maximum rate on pH provides additional evidence for a general-base catalyst. The pH-profile of kcat suggests that a group with a pKa of 6.1 must be unprotonated for activity. The peptide has no pK values in this pH range, and the pKa obtained for protonation of the γ-phosphate of ATP is 4.6 (30) so that the decrease in rate with changes in pH must reflect the titration of enzyme residues. The group with a pKa of 6.1 is most likely the general base.

An ATPase reaction that is intrinsic to the protein kinase provides an opportunity to estimate pKa’s from different enzyme forms. The pH-profiles of kcat and kcat/KATP of ATPase are bell-shaped (Figure 4). The pKa of the acidic limb is identical with that obtained from the kinase reaction within experimental error. In addition, since the pKa of the catalytic base is essentially the same when determined from the ATPase reaction under the condition representing free enzyme (6.5) and from the kinase reaction under the condition representing E:ATP:H1P (6.1), the presence of H1P and ATP in the active site does not affect the pKa of the base.

The potential role of Asp-126 as a general-base raises an interesting question regarding the role of the conserved aspartate in protein kinases. On the basis of available crystal structures, it is very likely that an aspartate residue within the hydrogen-bonding distance to the hydroxyl of the substrate is conserved in all protein kinases. This aspartate is clearly important for efficient catalysis, since replacement of it by alanine in PKA and PhK decreased kcat by 2–3 orders of magnitude. The role of this conserved aspartate has drawn considerable attention. Although a general-acid-base role has been given special consideration in the literature (29, 3133), many studies do not provide convincing evidence for a general-base catalyst. Instead, they support a positioning function of the conserved aspartate by attaining appropriate attack geometry between the hydroxyl group and γ phosphate of ATP (29). Alternatively, the aspartate could facilitate dissociation by repelling the phosphoproduct (34). Whether this carboxyl group serves the same function in other protein kinases is still unclear and further research is needed.

ABBREVIATIONS

AD

Alzheimer’s disease

Cdk5/p25

cyclin-dependent kinase5

H1P

histone H1-derived peptide PKTPKKAKKL

H1PAla

PKAPKKAKKL

H1PDaP

PKDapPKKAKKL

REFERENCES

  • 1.Baumann K, Mandelkow EM, Biernat J, Piwnica-Worms H, Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 1993;336:417–424. doi: 10.1016/0014-5793(93)80849-p. [DOI] [PubMed] [Google Scholar]
  • 2.Flaherty DB, Soria JP, Tomasiewicz HG, Wood JG. Phosphorylation of human tau protein by microtubule-associated kinases: GSK3beta and cdk5 are key participants. J Neurosci Res. 2000;62:463–472. doi: 10.1002/1097-4547(20001101)62:3<463::AID-JNR16>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
  • 3.Paudel HK, Lew J, Ali Z, Wang JH. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J Biol Chem. 1993;268:23512–23518. [PubMed] [Google Scholar]
  • 4.Ishiguro K, Takamatsu M, Tomizawa K, Omori A, Takahashi M, Arioka M, Uchida T, Imahori K. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J Biol Chem. 1992;267:10897–10901. [PubMed] [Google Scholar]
  • 5.Ishiguro K, Sato K, Takamatsu M, Park J, Uchida T, Imahori K. Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites. Neurosci Lett. 1995;202:81–84. doi: 10.1016/0304-3940(95)12206-0. [DOI] [PubMed] [Google Scholar]
  • 6.Lew J, Huang QQ, Qi Z, Winkfein RJ, Aebersold R, Hunt T, Wang JH. A brain-specific activator of cyclin-dependent kinase 5. Nature. 1994;371:423–426. doi: 10.1038/371423a0. [DOI] [PubMed] [Google Scholar]
  • 7.Tsai LH, Delalle I, Caviness VSJ, Chae T, Harlow E. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5. Nature. 1994;371:419–423. doi: 10.1038/371419a0. [DOI] [PubMed] [Google Scholar]
  • 8.Liu M, Choi S, Cuny GD, Ding K, Dobson BC, Glicksman MA, Auerbach K, Stein RL. Kinetic studies of Cdk5/p25 kinase: phosphorylation of tau and complex inhibition by two prototype inhibitors. Biochemistry. 2008;47:8367–8377. doi: 10.1021/bi800732v. [DOI] [PubMed] [Google Scholar]
  • 9.Romani A, Scarpa A. Regulation of cell magnesium. Arch Biochem Biophys. 1992;298:1–12. doi: 10.1016/0003-9861(92)90086-c. [DOI] [PubMed] [Google Scholar]
  • 10.Bhatnagar D, Roskoski RJ, Rosendahl MS, Leonard NJ. Adenosine cyclic 3',5'-monophosphate dependent protein kinase: a new fluorescence displacement titration technique for characterizing the nucleotide binding site on the catalytic subunit. Biochemistry. 1983;22:6310–6317. doi: 10.1021/bi00295a042. [DOI] [PubMed] [Google Scholar]
  • 11.Segel IH. enzyme kinetics. New York, NY: John Wiley & Sons; 1975. [Google Scholar]
  • 12.Cook PF. Kinetic studies to determine the mechanism of regulation of bovine liver glutamate dehydrogenase by nucleotide effectors. Biochemistry. 1982;21:113–116. doi: 10.1021/bi00530a020. [DOI] [PubMed] [Google Scholar]
  • 13.Cook PF, Neville MEJ, Vrana KE, Hartl FT, Roskoski RJ. Adenosine cyclic 3',5'-monophosphate dependent protein kinase: kinetic mechanism for the bovine skeletal muscle catalytic subunit. Biochemistry. 1982;21:5794–5799. doi: 10.1021/bi00266a011. [DOI] [PubMed] [Google Scholar]
  • 14.Gaffney TJ, O'Sullivan WJ. Kinetic studies of the activation of adenosine triphosphate-lombricine phosphotransferase by magnesium ions. Biochem. J. 1964;90:177–181. doi: 10.1042/bj0900177. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fromm HJ. Use of competitive inhibitors to study substrate binding order. Methods in Enzymology. 1979;63:467–486. doi: 10.1016/0076-6879(79)63020-3. [DOI] [PubMed] [Google Scholar]
  • 16.Sun G, Budde RJ. Requirement for an additional divalent metal cation to activate protein tyrosine kinases. Biochemistry. 1997;36:2139–2146. doi: 10.1021/bi962291n. [DOI] [PubMed] [Google Scholar]
  • 17.Vicario PP, Saperstein R, Bennun A. Role of divalent metals in the kinetic mechanism of insulin receptor tyrosine kinase. Arch. Biochem. Biophys. 1988;261:336–345. doi: 10.1016/0003-9861(88)90349-9. [DOI] [PubMed] [Google Scholar]
  • 18.Saylor P, Wang C, Hirai TJ, Adams JA. A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein v-Fps. Biochemistry. 1998;37:12624–12630. doi: 10.1021/bi9812672. [DOI] [PubMed] [Google Scholar]
  • 19.Armstrong RN, Kondo H, Granot J, Kaiser ET, Mildvan AS. Magnetic resonance and kinetic studies of the manganese(II) ion and substrate complexes of the catalytic subunit of adenosine 3',5'-monophosphate dependent protein kinase from bovine heart. Biochemistry. 1979;18:1230–1238. doi: 10.1021/bi00574a018. [DOI] [PubMed] [Google Scholar]
  • 20.Brown NR, Noble ME, Endicott JA, Johnson LN. The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases. Nat Cell Biol. 1999;1:438–443. doi: 10.1038/15674. [DOI] [PubMed] [Google Scholar]
  • 21.Sun G, Budde RJ. Requirement for an additional divalent metal cation to activate protein tyrosine kinases. Biochemistry. 1997;36:2139–2146. doi: 10.1021/bi962291n. [DOI] [PubMed] [Google Scholar]
  • 22.Matte A, Tari LW, Goldie H, Delbaere LT. Structure and mechanism of phosphoenolpyruvate carboxykinase. J Biol Chem. 1997;272:8105–8108. doi: 10.1074/jbc.272.13.8105. [DOI] [PubMed] [Google Scholar]
  • 23.Lovitt B, Vanderporten EC, Sheng Z, Zhu H, Drummond J, Liu Y. Differential effects of divalent manganese and magnesium on the kinase activity of leucine-rich repeat kinase 2 (LRRK2) Biochemistry. 2010;49:3092–3100. doi: 10.1021/bi901726c. [DOI] [PubMed] [Google Scholar]
  • 24.Lieser SA, Aubol BE, Wong L, Jennings PA, Adams JA. Coupling phosphoryl transfer and substrate interactions in protein kinases. Biochim Biophys Acta. 2005;1754:191–199. doi: 10.1016/j.bbapap.2005.07.024. [DOI] [PubMed] [Google Scholar]
  • 25.Schowen BK, Schowen RL. Solvent isotope effects on enzyme systems. Methods in Enzymology. 1982;87:551–606. [PubMed] [Google Scholar]
  • 26.Venkatasubban KS, Schowen RL. The proton inventory technique. Crit. Rev. Biochem. 1984;17:1–44. doi: 10.3109/10409238409110268. [DOI] [PubMed] [Google Scholar]
  • 27.Stein RL. Transition-state properties for the association of -1-protease inhibitor with porcine pancreatic elastase. J. Am. Chem. Soc. 1985;107:6039–6042. [Google Scholar]
  • 28.Cleland WW. Partition analysis and the concept of net rate constants as tools in enzyme kinetics. Biochemistry. 1975;14:3220–3224. doi: 10.1021/bi00685a029. [DOI] [PubMed] [Google Scholar]
  • 29.Zhou J, Adams JA. Is there a catalytic base in the active site of cAMP-dependent protein kinase? Biochemistry. 1997;36:2977–2984. doi: 10.1021/bi9619132. [DOI] [PubMed] [Google Scholar]
  • 30.Martell AE, Smith RM. Critical Stability Constants. Vol 5. New York: Plenum; 1982. [Google Scholar]
  • 31.Yoon MY, Cook PF. Chemical mechanism of the adenosine cyclic 3',5'-monophosphate dependent protein kinase from pH studies. Biochemsitry. 1987;26:4118–4125. doi: 10.1021/bi00387a056. [DOI] [PubMed] [Google Scholar]
  • 32.Ward WH, Cook PN, Slater AM, Davies DH, Holdgate GA, Green LR. Epidermal growth factor receptor tyrosine kinase. Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor. Biochem Pharmacol. 1994;48:659–666. doi: 10.1016/0006-2952(94)90042-6. [DOI] [PubMed] [Google Scholar]
  • 33.Adams JA. Insight into tyrosine phosphorylation in v-Fps using proton inventory techniques. Biochemistry. 1996;35:10949–10956. doi: 10.1021/bi960613h. [DOI] [PubMed] [Google Scholar]
  • 34.Madhusudan, Trafny EA, Xuong NH, Adams JA, Ten Eyck LF, Taylor SS, Sowadski JM. cAMP-dependent protein kinase: crystallographic insights into substrate recognition and phosphotransfer. Protein Sci. 1994;3:176–187. doi: 10.1002/pro.5560030203. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES